the component of MEF-ECM. The MEFs and MEF-ECM
were firmly fixed with a 4% paraformaldehyde solution for
15 minutes at room temperature. To facilitate permeability,
the specimens were treated with a 0.1% Triton X-100
solution for 10 minutes. Subsequently, the specimens
were blocked using a 1% bovine serum albumin (BSA,
Sigma, USA) solution for the next 30 minutes. Next,
primary antibodies including rabbit anti-laminin (1:100,
Invitrogen, USA), collagen I (1:300, BD Biosciences,
USA) and fibronectin (1:200, BD Biosciences, USA)
were utilized to incubate MEF-ECM samples overnight
at 4˚C. The MEF-ECM specimens underwent incubation
with Alexa Fluor-488 conjugated goat anti-rabbit (1:300,
Invitrogen, USA) in a dimly lit environment for an hour at
ambient temperature. The MEF samples were incubated
with Alexa Fluor-568 conjugated phalloidin (1:1000,
Cell Signaling Technology, USA) for 30 min at dark.
Subsequent to the completion of the staining process,
4,6-diamidino-2-phenylindole (DAPI, Invitrogen, USA)
was utilized to counterstain all samples within 10 minutes,
after which images were obtained under an inverted
fluorescence microscope (Leica Microsystems, Wetzlar,
Germany).